Intuitive Surgical (NASDAQ:ISRG) Price Target Raised to $575.00 at Jefferies Financial Group

Intuitive Surgical (NASDAQ:ISRGFree Report) had its price target boosted by Jefferies Financial Group from $475.00 to $575.00 in a research note published on Monday.

A number of other brokerages have also recently weighed in on ISRG. Evercore ISI reaffirmed a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. JPMorgan Chase & Co. increased their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday. Raymond James increased their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, Mizuho boosted their target price on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Get Our Latest Stock Report on ISRG

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $573.48 on Monday. The business has a 50 day simple moving average of $547.16 and a two-hundred day simple moving average of $505.21. Intuitive Surgical has a 12 month low of $364.17 and a 12 month high of $616.00. The stock has a market capitalization of $204.26 billion, a P/E ratio of 92.20, a PEG ratio of 5.19 and a beta of 1.39.

Insider Buying and Selling

In other news, CFO Jamie Samath sold 270 shares of the stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the transaction, the chief executive officer now owns 24,219 shares in the company, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 42,265 shares of company stock worth $21,964,281. 0.90% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in ISRG. Berbice Capital Management LLC bought a new stake in Intuitive Surgical in the fourth quarter valued at $26,000. Godsey & Gibb Inc. lifted its position in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new position in Intuitive Surgical during the 3rd quarter worth $33,000. Decker Retirement Planning Inc. acquired a new stake in Intuitive Surgical in the fourth quarter worth about $36,000. Finally, Capital Performance Advisors LLP acquired a new position in Intuitive Surgical in the third quarter valued at approximately $38,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

About Intuitive Surgical

(Get Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Stories

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.